Perfluorooctane sulfonic acid: a possible risk factor of endothelial dysfunction based on in silico and in vitro studies
- 17 April 2025
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (7) , 2975-2991
Abstract
Perfluorooctane sulfonic acid (PFOS) is a fluorinated chemical utilized in a variety of industrial and household products. PFOS has been detected in human serum and is associated with multiple human adverse health effects. Epidemiological evidence has linked PFOS exposure to endothelial dysfunction, which is a key contributor to atherosclerosis. However, the underlying mechanisms of PFOS-induced endothelial dysfunction associated atherosclerosis has not been investigated. In the present study, human microvascular endothelial cells (HMEC-1) exposed to PFOS (15 μM) for 72 h, mimicking long-term exposure. We further employed integrated RNA-sequencing (RNA-seq) and transcriptomic analysis to identify differentially expressed genes (DEGs) for biological alterations: gene ontology (GO), pathway enrichment analysis (KEGG), protein–protein interaction network and modular clustering analysis. Furthermore, the Metascape database was used for disease association, tissue specificity, and transcription factor analysis. Hub genes were verified using atherosclerosis patient data sets from the GEO dataset. Alteration of hub genes in patients was then validated using immunoblotting and ELISA. Our results revealed that PFOS altered amino acid biosynthesis, lipid metabolism and induced the ER-stress response through the HRI/eIF2α/ATF4 pathway, leading to endothelial dysfunction. Interestingly, we found that PFOS induced inflammation by increasing COX-2, ICAM-1 and IL-6 expression through NF-κB and JAK2/STAT3 pathway in endothelial cells. Moreover, up-regulated C/EBPβ and ATF4 were observed in both patients and PFOS-exposed endothelium, which may use as an early biomarker and may have a potential role in PFOS-induced endothelial dysfunction. These findings provide novel insight into the underlying molecular mechanisms of PFOS-induced endothelial dysfunction associated with atherosclerosis.Keywords
Funding Information
- Chulabhorn Graduate Scholarship Commemorating the 84th Birthday Anniversary of His Majesty King Bhumibol Adulyadej the Great (CGS (2021)/16)
This publication has 80 references indexed in Scilit:
- Principles of interleukin (IL)-6-type cytokine signalling and its regulationBiochemical Journal, 2003
- Immune activation and degradation of tryptophan in coronary heart diseaseEuropean Journal of Clinical Investigation, 2003
- Conserved Amino Acids within CCAAT Enhancer-binding Proteins (C/EBPα and β) Regulate Phosphoenolpyruvate Carboxykinase (PEPCK) Gene ExpressionJournal of Biological Chemistry, 2002
- CCAAT/enhancer-binding proteins: structure, function and regulationBiochemical Journal, 2002
- High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosisJournal of Clinical Investigation, 2000
- The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity FunctionsJournal of Biological Chemistry, 1998
- Effects of long-term exposure of human periodontal ligament cells to milk and other solutionsJournal of Endodontics, 1996
- trans-activation of the alpha 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptorJournal of Biological Chemistry, 1993
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.Genes & Development, 1991